Faculty

	Marjan Farid, MD Professor of Ophthalmology Director of Cornea, Cataract, and Refractive Surgery Vice Chair of Ophthalmic Faculty Gavin Herbert Eye Institute University of California, Irvine Irvine, California
	Anthony J. Aldave, MD Professor of Ophthalmology Walton Li Chair in Cornea and Uveitis Chief, Cornea and Uveitis Division Director, Cornea and Refractive Surgery Fellowship Program Doris Stein Eye Research Center Los Angeles, California
	Karolinne M. Rocha, MD, PhD Director, Cornea and Refractive Surgery Division Medical University of South Carolina Storm Eye Institute Mt Pleasant, South Carolina
	Christopher E. Starr, MD, FACS Associate Professor of Ophthalmology Director, Refractive Surgery Service Director, Ophthalmic Education Weill Cornell Medicine New York, New York

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

Faculty

Anthony J. Aldave, MD, is a consultant for Avellino Labs, ClearView Healthcare Partners, Dompé US, Inc, Gerson Lehrman Group, Inc, GlaxoSmithKline, Guidepoint, Health Advances LLC, LEK Consulting, Presbia PLC, and W. L. Gore & Associates, Inc; and receives honoraria from CorneaGen.

Marjan Farid, MD, is a consultant for Allergan, Bausch & Lomb Incorporated, Bio-Tissue, CorneaGen, Dompé US, Inc, Johnson & Johnson Vision Care, Inc, Kala Pharmaceuticals, Novartis Pharmaceuticals Corporation, Orasis Pharmaceuticals, Sun Pharmaceutical Industries, Inc, Tarsus Pharmaceuticals, Inc, and Zeiss.

Karolinne M. Rocha, MD, PhD, is a consultant for Dompé US, Inc.

Christopher E. Starr, MD, is a consultant for Aerie Pharmaceuticals, Inc, Aldeyra Therapeutics, Allergan, BlephEx, Bruder Healthcare, Dompé US, Inc, Èssiri Labs, Eyevance, Johnson & Johnson Vision Care, Inc, Kala Pharmaceuticals, Novartis Pharmaceuticals Corporation, Oculis, Oyster Point Pharma, Inc, Quidel Corporation, Sun Pharmaceutical Industries, Inc, Tarsus Pharmaceuticals, Inc, TearLab Corporation, and Visionology; and has stock options in Èssiri Labs and Visionology.

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners and Managers

MedEdicus planners and managers have no relevant commercial relationships to disclose.